These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 7429112

  • 1. Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV.
    De Franchis R, D'Arminio A, Vecchi M, Ronchi G, Del Ninno E, Parravicini A, Ferroni P, Zanetti AR.
    Gastroenterology; 1980 Sep; 79(3):521-7. PubMed ID: 7429112
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R, Campbell C, Wellinghoff W, Gelb L.
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [Abstract] [Full Text] [Related]

  • 4. [2-year follow-up of a series of cases of asymptomatic carriers of HBsAg antigen].
    Menicagli V.
    Arch Sci Med (Torino); 1982 Jul; 139(1):99-104. PubMed ID: 7103714
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B surface antigen carriers--to biopsy or not to biopsy.
    Koretz RL, Lewin KJ, Rebhun DJ, Gitnick GL.
    Gastroenterology; 1978 Nov; 75(5):860-3. PubMed ID: 700327
    [Abstract] [Full Text] [Related]

  • 6. Detection of e antigen and antibody: correlations with hapatitis B surface and hepatitis B core antigens, liver disease, and outcome in hepatitis B infections.
    Trepo CG, Magnius LO, Schaefer RA, Prince AM.
    Gastroenterology; 1976 Nov; 71(5):804-8. PubMed ID: 61146
    [Abstract] [Full Text] [Related]

  • 7. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L, García Bengoechea M, Cilla G, Gil I, yArenas JI.
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [Abstract] [Full Text] [Related]

  • 8. The role of HBV DNA and liver histopathology in HBsAg carriers.
    Agalar C, Diri C, Usubütün S, Agalar F, Türkyïlmaz R.
    Hepatogastroenterology; 1997 May; 44(16):1196-9. PubMed ID: 9261624
    [Abstract] [Full Text] [Related]

  • 9. [Natural history of the state of asymptomatic carrier of HBsAg: 7-year follow-up].
    Antoniozzi F, Meucci G, Vecchi M, Ronchi G, Collatina R, Del Ninno E, de Franchis R.
    Boll Ist Sieroter Milan; 1986 May; 65(5):347-53. PubMed ID: 3828089
    [Abstract] [Full Text] [Related]

  • 10. [Behavior and clinical significance of the eAg/ anti-e system in carriers of HBsAg].
    Pastore G, Dentico P, Fera G, Angarano G, Schiraldi O.
    Boll Ist Sieroter Milan; 1977 Sep; 56(4):333-8. PubMed ID: 911461
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
    Koçak N, Ozen H, Yüce A, Gürakan F.
    Turk J Pediatr; 1998 Sep; 40(3):365-72. PubMed ID: 9763900
    [Abstract] [Full Text] [Related]

  • 12. Laparoscopical and histological abnormalities of the liver in chronic HBs ag (hepatitis B surface antigen) carriers.
    Iwamura K.
    Tokai J Exp Clin Med; 1982 Jan; 7(1):43-51. PubMed ID: 6210975
    [Abstract] [Full Text] [Related]

  • 13. Full and empty Dane particles in chronic hepatitis B virus infection: relation to hepatitis B e antigen and presence of liver damage.
    Alberti A, Diana S, Scullard GH, Eddleston WF, Williams R.
    Gastroenterology; 1978 Nov; 75(5):869-74. PubMed ID: 700329
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic studies of asymptomatic HBsAg carriers: with special emphasis on carriers older than 40 years.
    Yang PM, Chen DS, Lai MY, Su IJ, Huang GT, Lin JT, Sheu JC, Hsu HC, Sung JL.
    Hepatogastroenterology; 1987 Dec; 34(6):251-4. PubMed ID: 3428857
    [Abstract] [Full Text] [Related]

  • 15. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 16. Laparoscopic an histologic abnormalities of the liver in chronic asymptomatic hepatitis B surface antigen carriers.
    Iwamura K.
    Tokai J Exp Clin Med; 1981 Oct; 6(4):385-91. PubMed ID: 7324079
    [Abstract] [Full Text] [Related]

  • 17. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
    Buongiorno R, Dentico P, Santantonio T, Frappampina V, Spinelli A, Amato M, Pastore G.
    Boll Soc Ital Biol Sper; 1980 Oct 30; 56(20):2076-82. PubMed ID: 7459119
    [Abstract] [Full Text] [Related]

  • 18. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF, Chadwick RG, Salmeron J, Shipton U, Thomas HC, Sherlock S.
    Gastroenterology; 1981 May 30; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
    Arase Y, Ikeda K, Suzuki F, Suzuki Y, Saitoh S, Kobayashi M, Akuta N, Someya T, Hosaka T, Sezaki H, Kobayashi M, Kumada H.
    Am J Med; 2006 Jan 30; 119(1):71.e9-16. PubMed ID: 16431195
    [Abstract] [Full Text] [Related]

  • 20. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S, Velu V, Nandakumar S, Madhavan V, Shanmugasundaram U, Shankar EM, Murugavel KG, Balakrishnan P, Kumarasamy N, Solomon S, Thyagarajan SP.
    J Microbiol Biotechnol; 2008 Oct 30; 18(10):1722-8. PubMed ID: 18955826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.